SUN2 and prostate cancer: The results of staining scoring in the 90 prostate cancer tissues and adjacent benign tissues showed that Sun2 expression was downregulated in prostate cancer (61/90,67.5%) (7.24 ± 4.42 vs. 3 .86 ± 3.3, P < 0.05) (Figure 1B).